Filter
871
Text search:
adverse
drug
reactions
Featured
119
248
Language
Document type
532
161
80
52
16
11
10
3
3
1
1
Countries / Regions
69
28
25
25
23
21
20
20
18
17
15
14
13
10
10
10
10
9
8
8
8
7
7
6
6
5
5
5
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
349
119
44
26
18
13
12
Toolboxes
129
79
66
50
44
34
27
18
17
17
14
8
8
8
6
5
4
4
3
3
3
3
3
1
Towards the Peoples Health Assembly Book -5
CHAPTER 15:03 | Acts 14/1969, 62/1971, 35/1974, 20/1978, 41/1978 (s. 35) 39/1979, 7/1987, 11/1988, 18/1989 (s. 27), 1/1996, 6/2000, 22/2001; R.G.N. 899/1978.
Blueprint for EECA countries, first edition
A Guide For Multicentre Trials in High-Burden Countries
Int J Vaccines Vaccin 2016, 2(1): 00018, January 29, 2016
4–15 February 2013
14–22 April 2015
Draft for consultation
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
Introduction
Chapter A.7
Introduction
Chapter A.9
Mood disorders
Chapter E.2
Mood disorders
Chapter E.3
2016 edition
Substance use disorders
Chapter G.3
H2 TIC disorders
recommended
Other disorders
Chapter H.5.1
Psychiatry and Pediatrics
Chapter I.5